Qinecsa Highlights - June 2024
Interview: Qinecsa's Latest Tech Innovations Revealed at DIA 2024?
Ahead of our first exhibition at the DIA Global Annual Meeting, Qinecsa spoke with Outsourcing Pharma about our latest breakthrough in clinical research technology, how it addresses the industry's current challenges and the major trends that will shape the future of pharmaceuticals.?
Qinecsa Unveils Newly Redesigned Website?
Qinecsa announced the launch of our newly redesigned website featuring a modern, user-friendly interface that allows visitors to easily access our wide-range of pharmacovigilance services and technologies. The updated site provides detailed information on all of our services, industry insights, and valuable resources for drug safety professionals, reflecting on our commitment to supporting life sciences companies in protecting patients’ lives.
Industry News: Pharmacovigilance Risk Assessment Committee's (PRAC) latest Meeting Highlights, 10-13 June
At its latest monthly meeting on 13-16 May, the Pharmacovigilance Risk Assessment Committee (PRAC) carried out its broad range of responsibilities, which cover all aspects of the risk management of the use of medicines: assessment of safety signals, risk management plans, periodic safety update reports and post-authorisation safety studies. In this particular meeting, the committee concluded that secondary malignancies of T-cell origin (a new cancer, different from the previous one, that begins in a type of white blood cells of the immune system called T-cells) may occur after treatment with chimeric antigen receptor (CAR) T-cell medicines.
Upcoming Event:? Insife Annual Convention 2024
We are pleased to announce that Humaira Qureshi, Qinecsa President, will be joining the list of?expert speakers at Insife's Annual Convention on 26th September in Basel, CH. This exciting full-day event will gather industry experts to connect, collaborate on tackling challenges, and explore the latest technology in the pharmacovigilance community.?
Upcoming Event: ISOP 2024 Annual Meeting
We are thrilled to announce that Qinecsa's President, Humaira Qureshi, will be part of the expert speaker panel at the ISoP Annual Meeting 2024, held from 1-5 October in Montreal, Canada. This prestigious conference will bring together leading pharmacovigilance professionals to discuss pivotal industry trends, collaborate on overcoming regulatory hurdles, and delve into cutting-edge advancements shaping the future of drug safety and surveillance.
Past Event: DIA Global USA 2024
Qinecsa was proud to exhibit for the first time at DIA Global's Annual 2024 meeting in San Diego, USA, for the conference's 60th anniversary! It was an amazing week for our commercial team to meet so many inspiring drug safety leaders and professionals. Heartfelt gratitude to everyone who helped make this event a success. Get a glimpse of behind the scenes of our team in San Diego. We look forward to exhibiting again next year in Washington!
领英推荐
Discover Qinecsa Technology - Are you ready to take your case intake and processing to the next level?
Introducing Qinecsa Technology Reportum, the globally recognized No. 1 digital capture tool for pharmacovigilance!
Reportum Key Features:
? Complete, relevant data capture on first interaction via web & mobile
? Eliminate manual data entry and reconciliation with automated E2B transfer
? Digital follow-up with a centralized, multi-lingual platform
?Join the revolution in digital case intake and follow-up for better patient safety and compliance with us. Schedule a demo to experience first-hand Reportum in action!
Watch our quick video below to see how we can transform your safety workflow.
Latest Resources:
Available on-demand - Medical Device Vigilance Expert Webinar
Get expert guidance on best practices and regulatory expectations in the intricate world of medical devices and drug-device combination products in the EU and US.
Thank you for being a part of the Qinecsa community. We look forward to keeping you informed and engaged!
Warm regards,
The Qinecsa Team
Qinecsa - Global specialists in technology-led end-to-end pharmacovigilance solutions!
We’d love to hear from you! Share your thoughts and feedback at [email protected]